New Vircell COVID-19 Serology Assays
Products are for professional/laboratory use only. Abacus dx is pleased to announce the launch of two new ELISA kits for the diagnosis of COVID-19 as well as two monotest kits for VirClia systems.
Serology allows confirmation of infection in symptomatic and asymptomatic patients.
|Reference||Description||Kit Contents||Insert Sheet|
|G1032||COVID-19 ELISA IgG||96 tests||View here >|
|MA1032||COVID-19 ELISA IgM+IgA||96 tests||View here >|
|VCM097||COVID-19 VIRCLIA IgG MONOTEST||24 tests||View here >|
|VCM098||COVID-19 VIRCLIA IgM+IgA MONOTEST||24 tests||View here >|
Main features of Vircell COVID-19 serology assays
- The use of SARS-CoV-2 recombinant antigens improves the performance of the kits.
- IgM + IgA detection complements molecular tests when the viral load decreases or when false negatives are suspected due to unsuitable samples in patients with clear symptoms.
- The combination of IgM + IgA significantly improves sensitivity since COVID-19 affects the mucous membrane. The early production of IgA antibodies in this kind of infections could be particularly high.
- IgG detection allows monitoring and confirming recovery and possible immunity, when other molecular and serological markers become negative.